Clinical Trials Directory

Trials / Completed

CompletedNCT03157232

Rainbow DCI vs. R1-25 Sensor SpHb Sub-Range Performance Equivalence

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Masimo Corporation · Industry
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

In this study, the concentration of hemoglobin was measured using noninvasive pulse oximeter sensors and compared against the hemoglobin measurement from the subject's blood sample under controlled conditions. Data collected in the study was in the sub-range of 11-17 g/dL in the device's 8-17 g/dL specification range. The purpose of the study was to evaluate a change in the sensor component and to assess performance equivalence in the sub-range. The performance of non-invasive hemoglobin is not uniform across the accuracy range.

Conditions

Interventions

TypeNameDescription
DEVICERainbow DCI and R1-25 sensorNoninvasive Measurement of SpHb

Timeline

Start date
2009-06-19
Primary completion
2009-06-29
Completion
2009-06-29
First posted
2017-05-17
Last updated
2017-07-27
Results posted
2017-07-27

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03157232. Inclusion in this directory is not an endorsement.